Evergreen Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Buy |
7,868
+327
| +4% | +$35.1K | 0.03% | 401 |
|
|
2025
Q1 | $761K | Buy |
7,541
+1,210
| +19% | +$122K | 0.03% | 383 |
|
|
2024
Q4 | $565K | Buy |
6,331
+106
| +2% | +$9.47K | 0.02% | 465 |
|
|
2024
Q3 | $522K | Buy |
6,225
+275
| +5% | +$23K | 0.02% | 484 |
|
|
2024
Q2 | $458K | Buy |
5,950
+1,315
| +28% | +$101K | 0.02% | 495 |
|
|
2024
Q1 | $317K | Buy |
4,635
+249
| +6% | +$17.1K | 0.01% | 602 |
|
|
2023
Q4 | $254K | Buy |
4,386
+176
| +4% | +$10.2K | 0.01% | 670 |
|
|
2023
Q3 | $222K | Sell |
4,210
-180
| -4% | -$9.5K | 0.01% | 665 |
|
|
2023
Q2 | $237K | Buy |
+4,390
| New | +$237K | 0.01% | 652 |
|